Nanobodies as modulators of inflammation: potential applications for acute brain injury
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Nanobodies as modulators of inflammation: potential applications for acute brain injury
Authors
Keywords
-
Journal
Frontiers in Cellular Neuroscience
Volume 8, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2014-10-21
DOI
10.3389/fncel.2014.00344
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- ATP Signaling in Brain: Release, Excitotoxicity and Potential Therapeutic Targets
- (2014) Abraham Cisneros-Mejorado et al. CELLULAR AND MOLECULAR NEUROBIOLOGY
- A novel platform for engineering blood-brain barrier-crossing bispecific biologics
- (2014) Graham K. Farrington et al. FASEB JOURNAL
- High efficiency cell-specific targeting of cytokine activity
- (2014) Geneviève Garcin et al. Nature Communications
- Nanobodies: Natural Single-Domain Antibodies
- (2013) Serge Muyldermans Annual Review of Biochemistry
- Efflux of monoclonal antibodies from rat brain by neonatal Fc receptor, FcRn
- (2013) Philip R. Cooper et al. BRAIN RESEARCH
- Blockade of CXCR1/2 chemokine receptors protects against brain damage in ischemic stroke in mice: Ischemia and Reparixin
- (2013) LF Sousa et al. Clinics
- The art of blocking ADP-ribosyltransferases (ARTs): Nanobodies as experimental and therapeutic tools to block mammalian and toxin ARTs
- (2013) Stephan Menzel et al. FEBS Journal
- Neutralizing Nanobodies Targeting Diverse Chemokines Effectively Inhibit Chemokine Function
- (2013) Christophe Blanchetot et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Llama-derived Single Variable Domains (Nanobodies) Directed against Chemokine Receptor CXCR7 Reduce Head and Neck Cancer Cell Growthin Vivo
- (2013) David Maussang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Inhibition of CXCL12 Signaling Attenuates the Postischemic Immune Response and Improves Functional Recovery after Stroke
- (2013) Karsten Ruscher et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Technical Advance: A new cell preparation strategy that greatly improves the yield of vital and functional Tregs and NKT cells
- (2013) Björn Rissiek et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Single-Domain Antibody-Based and Linker-Free Bispecific Antibodies Targeting Fc RIII Induce Potent Antitumor Activity without Recruiting Regulatory T Cells
- (2013) C. Rozan et al. MOLECULAR CANCER THERAPEUTICS
- Nanobodies and their potential applications
- (2013) Gholamreza Hassanzadeh-Ghassabeh et al. Nanomedicine
- Small nanobody drugs win big backing from pharma
- (2013) Sarah CP Williams NATURE MEDICINE
- Engineering a lysosomal enzyme with a derivative of receptor-binding domain of apoE enables delivery across the blood-brain barrier
- (2013) D. Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Immune mechanisms of stroke
- (2012) Tim Magnus et al. CURRENT OPINION IN NEUROLOGY
- Cell-penetrating anti-GFAP VHH and corresponding fluorescent fusion protein VHH-GFP spontaneously cross the blood-brain barrier and specifically recognize astrocytes: application to brain imaging
- (2012) Tengfei Li et al. FASEB JOURNAL
- Drug Transport across the Blood–Brain Barrier
- (2012) William M Pardridge JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- CXCR4 Antagonist AMD3100 Protects Blood–Brain Barrier Integrity and Reduces Inflammatory Response After Focal Ischemia in Mice
- (2012) Jun Huang et al. STROKE
- The immunology of stroke: from mechanisms to translation
- (2011) Costantino Iadecola et al. NATURE MEDICINE
- P2X7 receptor blockade prevents ATP excitotoxicity in neurons and reduces brain damage after ischemia
- (2011) Joana Arbeloa et al. NEUROBIOLOGY OF DISEASE
- CD38 Exacerbates Focal Cytokine Production, Postischemic Inflammation and Brain Injury after Focal Cerebral Ischemia
- (2011) Chi-un Choe et al. PLoS One
- Mesenchymal Stem Cells Primed With Valproate and Lithium Robustly Migrate to Infarcted Regions and Facilitate Recovery in a Stroke Model
- (2011) Li-Kai Tsai et al. STROKE
- Extracellular NAD+shapes the Foxp3+regulatory T cell compartment through the ART2–P2X7 pathway
- (2010) Sandra Hubert et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Averting inflammation by targeting the cytokine environment
- (2010) Manfred Kopf et al. NATURE REVIEWS DRUG DISCOVERY
- CXCR4 nanobodies (VHH-based single variable domains) potently inhibit chemotaxis and HIV-1 replication and mobilize stem cells
- (2010) S. Jahnichen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A one-step exclusion-binding procedure for the purification of functional heavy-chain and mammalian-type γ-globulins from camelid sera
- (2009) Michel R. Blanc et al. BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY
- Llama single-domain antibodies directed against nonconventional epitopes of tumor-associated carcinoembryonic antigen absent from nonspecific cross-reacting antigen
- (2009) Ghislaine Behar et al. FEBS Journal
- A recombinant heavy chain antibody approach blocks ART2 mediated deletion of an iNKT cell population that upon activation inhibits autoimmune diabetes
- (2009) Felix Scheuplein et al. JOURNAL OF AUTOIMMUNITY
- Single domain antibodies: promising experimental and therapeutic tools in infection and immunity
- (2009) Janusz Wesolowski et al. MEDICAL MICROBIOLOGY AND IMMUNOLOGY
- Orally administered L. lactis secreting an anti-TNF Nanobody demonstrate efficacy in chronic colitis
- (2009) K Vandenbroucke et al. Mucosal Immunology
- Post-ischemic brain damage: pathophysiology and role of inflammatory mediators
- (2008) Diana Amantea et al. FEBS Journal
- The HMGB1 Receptor RAGE Mediates Ischemic Brain Damage
- (2008) S. Muhammad et al. JOURNAL OF NEUROSCIENCE
- Improved tumor targeting of anti-epidermal growth factor receptor Nanobodies through albumin binding: taking advantage of modular Nanobody technology
- (2008) B. M. Tijink et al. MOLECULAR CANCER THERAPEUTICS
- Single-domain antibody fragments with high conformational stability
- (2002) Mireille Dumoulin et al. PROTEIN SCIENCE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started